Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced ...

J.P. Morgan releases its quarterly look-ahead days before the entire biopharma industry descends on San Francisco for the ...

In a report released on January 7, Jeremy Tonet from J.P. Morgan maintained a Buy rating on Constellation Energy Corporation (CEG – Research ...

Advisers from one of the world's largest investment banks, J.P. Morgan, delivered a glowing review on Wednesday of the Churchill Falls MOU, saying it offers the necessary guardrails to ensure the ...

The Los Angeles wildfires are now expected to exceed $20B, J.P. Morgan analyst Jimmy Bhullar estimated Thursday, doubling his ...

The fires, which are still not under control and have killed at least five people, are likely to cost more than $50 billion in overall losses, the analysts said. Late Thursday, Accuweather pinned the ...

A preliminary report by Accuweather estimated the cost of the wildfires ravaging L.A. County at more than $50 billion, a ...

The U.S. auto industry is bracing for a shifting landscape, marked by the economic policies and global trade strategies of a ...

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan’s 43rd Annual Healthcare ...

FY2024 revenue up 7% YoY, driven by international demand. Find out why I am upgrading CTKB stock from Hold to Buy.

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Savvy also welcomed Samuel Saleh, a Newport Beach, Calif.-based advisor with $50 million in AUM, who was previously with Bank ...